Mary T. Szela, CEO AND PRESIDENT at TriSalus Life Sciences, Inc. (TLSI), bought 5,000 shares at $4.97 ($25K) on 2024-09-10, disclosed to the SEC on 2024-09-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TLSI | SELL | 2026-03-20 | $79K | — | Filing → |
| TLSI | BUY | 2026-02-23 | $125K | — | Filing → |
| TLSI | BUY | 2025-01-31 | $52K | — | Filing → |